You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

somatostatin receptors

Showing 1 - 25 of 2,176
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Somatostatin Receptors and GH Receptor Expression on Bone of

Completed
  • Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
  • Trans-sphenoidal surgery
  • Roma, Italy
    Fondazione Policlinnico Gemelli IRCCS
Apr 6, 2023

Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

Not yet recruiting
  • Neuroblastoma
  • PRRT with 177Lu-DOTATATE
  • Lille, France
  • +2 more
Nov 8, 2022

Infective Endocarditis Trial (68Ga-DOTATOC PET/CT)

Not yet recruiting
  • Infective Endocarditis
  • 68Ga-DOTATOC PET/CT
  • (no location specified)
Dec 21, 2021

Multiple Myeloma Trial in Brussels (Gallium-68 labelled DOTA-conjugated SSTR targeting peptide PET/CT)

Recruiting
  • Multiple Myeloma
  • Gallium-68 labelled DOTA-conjugated SSTR targeting peptide PET/CT
  • Brussels, Belgium
    Jules Bordet Institute
Oct 7, 2021

Neuroendocrine Tumors Trial in Sherbrooke (Gallium-68 DOTA TATE PET scan)

Completed
  • Neuroendocrine Tumors
  • Gallium-68 DOTA TATE PET scan
  • Sherbrooke, Quebec, Canada
    Centre hospitalier universitaire de Sherbrooke
May 17, 2021

Neuroendocrine Tumors Trial in Edmonton ([68]Ga-HA-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jun 18, 2021

Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy (PRRT) Trial in Ferrara (Lutetium-177 (177Lu)-DOTATOC, Yttrium-90

Recruiting
  • Neuroendocrine Tumors
  • Peptide Receptor Radionuclide Therapy (PRRT)
  • Lutetium-177 (177Lu)-DOTATOC
  • +4 more
  • Ferrara, Italy
    University Hospital of Ferrara
Mar 5, 2021

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Carcinoid Cancer, Neuroendocrine Tumors, Medullary Thyroid Cancer Trial in Los Angeles (68Ga DOTATATE)

No longer available
  • Carcinoid Cancer
  • +3 more
  • 68Ga DOTATATE
  • Los Angeles, California
    UCLA Hospital
Jul 23, 2020

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • FDG-PET
  • Galium-68 DOTATATE
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022

Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor

Recruiting
  • PET / CT
  • +3 more
  • 68Ga-DOTA-TATE PET/MR and PET/CT imaging
  • Wuhan, Hubei, China
    China, Hubei Province
Apr 26, 2022

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

Active, not recruiting
  • Neuroendocrine Carcinoma
  • Lu-DOTA-TATE
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 5, 2022

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)

Recruiting
  • Metastic Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Myocarditis Trial in Vandoeuvre/les/nancy (DOTATOC-68Ga PET initial, DOTATOC-68Ga PET at 6 months, blood sample)

Recruiting
  • Myocarditis
  • DOTATOC-68Ga PET initial
  • +2 more
  • Vandoeuvre/les/nancy, France
    Véronique ROCH
Aug 3, 2021

Pituitary Tumours Trial in Göteborg (Gallium-68 DOTATOC PET)

Terminated
  • Pituitary Tumours
  • Gallium-68 DOTATOC PET
  • Göteborg, Sweden
    Center of Endocrinology and Metabolism, Sahlgrenska university H
Mar 15, 2022

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of

Recruiting
  • Cardiac Sarcoidosis
  • 64Cu-DOTATATE PET/CT scan
  • Copenhagen, Denmark
    Rigshospitalet
Nov 14, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

Recruiting
  • Pulmonary Neuroendocrine Neoplasm
  • +9 more
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jul 9, 2021

Meningioma Trial in Basel (177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over), 177Lu-DOTATOC (Phase 0); Cycle 1 and

Recruiting
  • Meningioma
  • 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over)
  • +2 more
  • Basel, Basel-Stadt, Switzerland
    University Hospital Basel, Department of Neurosurgery
Aug 2, 2021

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023